Common variance! [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2012-06-12 22:39 (5116 d 23:35 ago) – Posting: # 8721
Views: 11,178

Hi John!

❝ Could I hypothetically strip the two treatments (successful test formulation and the reference) and re-run stats in a two-way crossover fashion to re-evaulate the data?

(my emphasis)

See this goody (slides 60–67). The title Don’t try this at home! tells it all. You are not the first one having such an idea (see also here).

❝ Would that stand a chance with regulatory?


Close to nil – unless you run sufficiently large simulations demonstrating that the patient’s risk is preserved. Not a trivial job.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
140 visitors (0 registered, 140 guests [including 16 identified bots]).
Forum time: 22:15 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5